These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 23727436)

  • 1. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.
    Louhivuori V; Vicario A; Uutela M; Rantamäki T; Louhivuori LM; Castrén E; Tongiorgi E; Akerman KE; Castrén ML
    Neurobiol Dis; 2011 Feb; 41(2):469-80. PubMed ID: 21047554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF-induced local protein synthesis and synaptic plasticity.
    Leal G; Comprido D; Duarte CB
    Neuropharmacology; 2014 Jan; 76 Pt C():639-56. PubMed ID: 23602987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF mechanisms in late LTP formation: A synthesis and breakdown.
    Panja D; Bramham CR
    Neuropharmacology; 2014 Jan; 76 Pt C():664-76. PubMed ID: 23831365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome.
    Nomura T; Musial TF; Marshall JJ; Zhu Y; Remmers CL; Xu J; Nicholson DA; Contractor A
    J Neurosci; 2017 Nov; 37(47):11298-11310. PubMed ID: 29038238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
    Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
    Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus.
    Yun SH; Trommer BL
    J Neurosci Res; 2011 Feb; 89(2):176-82. PubMed ID: 21162125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-dependent alterations in the sensitivity to BDNF-TrkB signaling may promote excessive dendritic arborization and spinogenesis in fragile X syndrome in order to compensate for compromised postsynaptic activity.
    Kim SW; Cho KJ
    Med Hypotheses; 2014 Oct; 83(4):429-35. PubMed ID: 25113167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
    Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
    Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired bidirectional NMDA receptor dependent synaptic plasticity in the dentate gyrus of adult female Fmr1 heterozygous knockout mice.
    Yau SY; Bostrom CA; Chiu J; Fontaine CJ; Sawchuk S; Meconi A; Wortman RC; Truesdell E; Truesdell A; Chiu C; Hryciw BN; Eadie BD; Ghilan M; Christie BR
    Neurobiol Dis; 2016 Dec; 96():261-270. PubMed ID: 27659109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.
    Bostrom CA; Majaess NM; Morch K; White E; Eadie BD; Christie BR
    Cereb Cortex; 2015 Jan; 25(1):271-9. PubMed ID: 23968838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased coupling of caveolin-1 and estrogen receptor α contributes to the fragile X syndrome.
    Yang Q; Yang L; Zhang K; Guo YY; Liu SB; Wu YM; Li XQ; Song Q; Zhuo M; Zhao MG
    Ann Neurol; 2015 Apr; 77(4):618-36. PubMed ID: 25611593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
    Berry-Kravis E
    Pediatr Neurol; 2014 Apr; 50(4):297-302. PubMed ID: 24518745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
    Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
    Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
    Zhang L; Alger BE
    J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational endpoints in fragile X syndrome.
    de Esch CE; Zeidler S; Willemsen R
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():256-69. PubMed ID: 24184744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.